Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
B Chen
Institutions:
Mayo Clinic,
Seattle Cancer Care Alliance,
Memorial Sloan Kettering Cancer Center,
Aristotle University of Thessaloniki,
Yale University,
UPMC Hillman Cancer Center,
University General Hospital Attikon,
Mayo Clinic in Florida
show all 8
Observed institutions:
Mayo Clinic,
Seattle Cancer Care Alliance,
Memorial Sloan Kettering Cancer Center,
Aristotle University of Thessaloniki,
Yale University,
Mayo Clinic in Arizona,
UPMC Hillman Cancer Center,
University General Hospital Attikon,
Mayo Clinic in Florida
show all 9
OpenAlex ID:
A5044209489
Abstract S5-4: EGFR expression measured by quantitative immunofluorescense is associated with decreased benefit from trastuzumab in the adjuvant setting in the NCCTG (Alliance) N9831 trial.
2012
·
D Rimm
, KV Ballman
, et al.
·
Cancer Research
·
8
PD05-04: Quantitative Measurement of Antigen Degradation in NCCTG N9831 Tissue Microarrays.
2011
·
H Cheng
, DL Rimm
, et al.
·
Cancer Research
Show more works
View as search
Works count:
2
Citation count:
8
H-index:
1
I10-index:
Year
Topic
Type
